Does interleukin-18 or tumour necrosis factor-alpha have an independent association with the risk of coronary heart disease? Results from a prospective study in New Zealand

Cytokine. 2010 Apr;50(1):94-8. doi: 10.1016/j.cyto.2009.12.014. Epub 2010 Jan 21.

Abstract

Background: The pro-inflammatory cytokines, interleukin (IL)-18 and tumour necrosis factor-alpha (TNFalpha) may play a role in coronary heart disease (CHD). We aimed to extend data on their relationships to the risk of CHD in generally healthy populations.

Methods: During 5.5years follow-up in the Fletcher Challenge general population cohort there were 256 CHD cases, and 615 controls were matched for age and sex. Baseline plasma levels of IL-18 and TNFalpha were related to CHD risk in available samples (77%).

Results: Plasma levels of IL-18 (11% increase in mean, p=0.01) and TNFalpha (10% increase in mean p=0.024) were significantly elevated in CHD cases versus controls. In univariable models IL-18 was associated with CHD risk (odds ratio [OR] upper third to lower third, 1.63; 95% CI 1.08, 2.46), but TNFalpha was not (OR 1.33; 95% CI 0.87, 2.02).After adjusting for major CHD risk factors and CRP, the association of IL-18 with CHD risk was attenuated (OR 1.69; 95% CI 0.94, 3.03).

Conclusions: IL-18, but not TNFalpha, had a non-negligible association with CHD risk, although the association of IL-18 with risk was weak after full adjustment. These cytokines may play a role in CHD pathology, but may not be robust risk biomarkers.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Case-Control Studies
  • Coronary Disease / genetics*
  • Follow-Up Studies
  • Genetic Predisposition to Disease*
  • Humans
  • Interleukin-18 / genetics*
  • New Zealand
  • Odds Ratio
  • Prospective Studies
  • Tumor Necrosis Factor-alpha / genetics*

Substances

  • Interleukin-18
  • Tumor Necrosis Factor-alpha